LP appetite for Asia weakens - survey
Institutional investor interest in Asia has fallen significantly over the past two years, according to a survey conducted by Probitas Partners, with pan-regional funds, venture capital, and single country-focused funds among the least popular strategies globally.
Of the 70 respondents, which included pension funds, endowments and foundations, and fund-of-funds, only 7% expressed an interest in country-focused funds – a segment of the market typically dominated...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.